Similar articles for PMID: 28374163

Year	Number of Results
1975	1
1985	1
1987	5
1988	4
1989	5
1990	3
1991	8
1992	1
1993	9
1994	5
1995	6
1996	6
1997	11
1998	5
1999	11
2000	11
2001	12
2002	16
2003	10
2004	10
2005	8
2006	13
2007	10
2008	11
2009	11
2010	13
2011	2
2012	6
2013	10
2014	13
2015	16
2016	22
2017	20
2018	17
2019	23
2020	15
2021	16
2022	14
2023	2
2024	0

1

Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomas.

Tessoulin B, Thomare P, Delande E, Moynard J, Gastinne T, Moreau A, Bossard C, Mahé B, Blin N, Dubruille V, Touzeau C, Boudreault JS, Perrin F, Lok A, Guillaume T, Garnier A, Peterlin P, Gallas P, Chevallier P, Moreau P, Le Gouill S. Tessoulin B, et al. Ann Hematol. 2017 Jun;96(6):943-950. doi: 10.1007/s00277-017-2981-2. Epub 2017 Apr 3. Ann Hematol. 2017. PMID: 28374163

2

Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.

Abali H, Urün Y, Oksüzoğlu B, Budakoğlu B, Yildirim N, Güler T, Ozet G, Zengin N. Abali H, et al. Cancer Invest. 2008 May;26(4):401-6. doi: 10.1080/07357900701788098. Cancer Invest. 2008. PMID: 18443961

3

Mitoxantrone-DHAP with GM-CSF: an active but myelosuppressive salvage therapy for relapsed/refractory aggressive non-Hodgkin's lymphoma.

Haq R, Sawka CA, Franssen E, Berinstein NL. Haq R, et al. Leuk Lymphoma. 1999 Nov;35(5-6):527-36. doi: 10.1080/10428199909169617. Leuk Lymphoma. 1999. PMID: 10609790 Clinical Trial.

4

High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study.

Josting A, Sieniawski M, Glossmann JP, Staak O, Nogova L, Peters N, Mapara M, Dörken B, Ko Y, Metzner B, Kisro J, Diehl V, Engert A. Josting A, et al. Ann Oncol. 2005 Aug;16(8):1359-65. doi: 10.1093/annonc/mdi248. Epub 2005 Jun 6. Ann Oncol. 2005. PMID: 15939712 Free article. Clinical Trial.

5

Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.

Schütt P, Passon J, Ebeling P, Welt A, Müller S, Metz K, Moritz T, Seeber S, Nowrousian MR. Schütt P, et al. Eur J Haematol. 2007 Feb;78(2):93-101. doi: 10.1111/j.1600-0609.2006.00796.x. Eur J Haematol. 2007. PMID: 17313557 Clinical Trial.

6

Time-intensified dexamethasone/cisplatin/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease.

Josting A, Rudolph C, Reiser M, Mapara M, Sieber M, Kirchner HH, Dörken B, Hossfeld DK, Diehl V, Engert A; Participating Centers. Josting A, et al. Ann Oncol. 2002 Oct;13(10):1628-35. doi: 10.1093/annonc/mdf221. Ann Oncol. 2002. PMID: 12377653 Free article. Clinical Trial.

7

Rituximab, dexamethasone, cytarabine, and oxaliplatin (R-DHAX) is an effective and safe salvage regimen in relapsed/refractory B-cell non-Hodgkin lymphoma.

Lignon J, Sibon D, Madelaine I, Brice P, Franchi P, Briere J, Mounier N, Gisselbrecht C, Faure P, Thieblemont C. Lignon J, et al. Clin Lymphoma Myeloma Leuk. 2010 Aug;10(4):262-9. doi: 10.3816/CLML.2010.n.055. Clin Lymphoma Myeloma Leuk. 2010. PMID: 20709662

8

The effect of the dexamethasone, cytarabine, and cisplatin (DHAP) regimen on stem cell mobilization and transplant outcomes of patients with non-Hodgkin's lymphoma who are candidates for up-front autologous stem cell transplantation.

Jeon SY, Yhim HY, Kim HS, Kim JA, Yang DH, Kwak JY. Jeon SY, et al. Korean J Intern Med. 2018 Nov;33(6):1169-1181. doi: 10.3904/kjim.2016.163. Epub 2018 Jan 8. Korean J Intern Med. 2018. PMID: 29295612 Free PMC article.

9

Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma.

Hänel M, Kröger N, Kroschinsky F, Birkmann J, Hänel A, Herbst R, Naumann R, Friedrichsen K, Ehninger G, Zander AR, Fiedler F. Hänel M, et al. J Cancer Res Clin Oncol. 2001;127(6):387-95. doi: 10.1007/s004320000226. J Cancer Res Clin Oncol. 2001. PMID: 11414199 Clinical Trial.

10

An oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin's lymphoma.

Chau I, Webb A, Cunningham D, Hill M, Rao S, Ageli S, Norman A, Gill K, Howard A, Catovsky D. Chau I, et al. Br J Haematol. 2001 Dec;115(4):786-92. doi: 10.1046/j.1365-2141.2001.03181.x. Br J Haematol. 2001. PMID: 11843810 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

343 results

Results by year